Insulet

Yahoo Finance • 2 days ago

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus

Wall Street’s major market averages ended higher on Friday as investors digested the latest nonfarm payrolls print and sidestepped the ongoing tensions in the Middle East. The blue-chip Dow added +0.1%, the benchmark S&P 500 closed +0.8%,... Full story

Yahoo Finance • 3 days ago

Most healthcare companies report higher Y/Y EPS in strong earnings week

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare companies delivered strong earnings this week, with 18 out of 20 companies beating EPS estimates and 15 t... Full story

Yahoo Finance • 6 days ago

Insulet Corporation Q1 2026 Earnings Call Summary

Insulet Corporation Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers Achieved 30% constant currency revenue growth, driven by robust international expansion and continued adoption of Omnipod 5 across type 1 and type 2 s... Full story

Yahoo Finance • 13 days ago

Insulet (PODD) Ends April With Strong Analyst Sentiment Amid Strong Earnings Expectations

With one-year EPS and revenue growth estimates of 27.44% and 19.19%, respectively, Insulet Corporation (NASDAQ:PODD) earns a place on our list of the best growth stocks to buy and hold in 2026.Insulet (PODD) Ends April With Strong Analyst... Full story

Yahoo Finance • 15 days ago

2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 We Turn Down

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about com... Full story

Yahoo Finance • 16 days ago

Jim Cramer Has A Clear Take On Rivian's Future — And A Warning About An AI Name

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Critical Metals Corp. is a spec. “If you really want to be in that industry, you need to buy MP Materials,” he added. According to recent news, the company announced on Tuesday a priv... Full story

Yahoo Finance • 16 days ago

Jim Cramer on Insulet Corporation: “It’s Still Too Expensive Because of the GLP-1 Threat”

Insulet Corporation (NASDAQ:PODD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Toward the end of the lightning round, a caller sought Cramer’s opinion of the stock, and h... Full story

Yahoo Finance • 18 days ago

Intel upgraded, DraftKings downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Roth Capital upgraded Intel (INTC) to... Full story

Yahoo Finance • 19 days ago

Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Insulin Delivery System Market size & share revenue was valued at approxima... Full story

Yahoo Finance • 22 days ago

Is Insulet Corporation (PODD) One of the Most Oversold Healthcare Stocks to Invest In?

Insulet Corporation (NASDAQ:PODD) is one of the most oversold healthcare stocks to invest in. Insulet Corporation (NASDAQ:PODD) received a rating update from Truist on April 15. The firm cut the price target on the stock to $315 from $360... Full story

Yahoo Finance • 26 days ago

Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings

[Futuristic laboratory equipment. DNA research on computer screens] janiecbros/E+ via Getty Images Abbott Laboratories (ABT [https://seekingalpha.com/symbol/ABT]) kicked off Q1 2026 earnings season with a mixed report, where revenue grew... Full story

Yahoo Finance • last month

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD). Such investors are advised to contact Danielle Peyton at newact... Full story

Yahoo Finance • last month

Insulet (PODD) Appoints Mike Panos as Chief Commercial Officer

Insulet Corporation (NASDAQ:PODD) is one of the 8 Most Oversold Strong Buy-Rated Stocks to Invest In. On March 30, 2026, Insulet Corporation (NASDAQ:PODD) announced the appointment of Mike Panos as Executive Vice President and Chief Comme... Full story

Yahoo Finance • last month

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More

Quick Read The stock market started the first full trading week of the second quarter on a positive note. Investors and analysts will be anxiously awaiting first-quarter earnings results that will start in earnest next week with the large... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • last month

Truist Maintains Insulet Corporation (PODD) Buy Rating Despite Device Correction Announcement

We recently compiled a list of the 10 Quality Value Stocks Likely to Make a Comeback According to Analysts. Insulet Corporation is among the best value stocks. TheFly reported on March 13 that Truist observed that PODD shares declined aft... Full story

Yahoo Finance • 2 months ago

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 2 months ago

Danaher Achieves #26 Analyst Rank, Surpassing Insulet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #26 spot from Insulet Corp (Symbol: PODD), according to ETF Channel. Below is a cha... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus

Wall Street's major averages closed deep in the red on Friday, with oil sustaining higher prices even as Israeli Prime Minister Netanyahu said the country is helping to reopen the Strait of Hormuz. The benchmark S&P 500 ended -1.5%, while... Full story

Yahoo Finance • 2 months ago

1 Healthcare Stock with Exciting Potential and 2 We Avoid

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 3.6% ga... Full story